Disparities During the COVID-19 Pandemic in SARS-CoV-2 Testing Increased After a Federal Government’s At-Home Testing Distribution Program Compared with Before in a U.S. Urban Setting

Diagnostic testing is essential for controlling the transmission of infectious diseases. During the COVID-19 pandemic, testing became widely available in the United States. However, the association between a federal at-home COVID-19 rapid antigen test distribution program and sociodemographics and COVID-19 testing remains unknown. This secondary analysis aims to (1) assess the association between the federal at-home testing program and testing uptake and (2) examine associations, including interactions with the testing program, between sociodemographic characteristics, testing experience, and COVID-19 testing. We analyzed baseline data collected from February 2021 to November 2022 in a randomized comparative effectiveness parent trial conducted in a mid-Atlantic U.S. city ( N = 1859). Logistic regression models with robust standard errors were used. Overall, 79.9% (1486) of participants reported receiving a COVID-19 test. Exposure to the federal testing program (odds ratio [OR] = 2.25; 95% confidence interval [CI]: 1.61, 3.13), higher education (OR = 1.36; 95% CI: 1.02, 1.80), private health insurance (OR = 2.03; 95% CI: 1.41, 2.92), higher household income (OR = 1.49; 95% CI: 1.06, 2.09), and ease of testing access (OR = 1.40; 95% CI: 1.04, 1.87) were significantly associated with testing. After adjustment, private insurance (adjusted OR [aOR] = 1.61; 95% CI: 1.12, 2.31) and higher income (aOR = 1.50; 95% CI: 1.12, 2.02) remained associated with testing. The adjusted odds of COVID-19 testing were 2-fold higher (aOR = 2.21; 95% CI: 1.21, 4.04) for high-income (vs. low-income) households during the federal at-home COVID-19 rapid antigen testing program than before its implementation. Disparities in COVID-19 testing by socioeconomic status increased during the federal testing program compared with the period before its implementation. Ensuring equitable access to diagnostic testing remains critical for an effective public health response.

Authors

Institutions

Publication Details

Journal
Population Health Management
Published
2026-11-18
DOI
https://doi.org/10.1177/19427891261508847
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disparities During the COVID-19 Pandemic in SARS-CoV-2 Testing Increased After a Federal Government’s At-Home Testing Distribution Program Compared with Before in a U.S. Urban Setting

Shruti H. Mehta, Jacky M. Jennings, Jason E. Farley, Saifuddin Ahmed et al.
Population Health Management
SARS-CoV-2 detection and testing
article

Disparities During the COVID-19 Pandemic in SARS-CoV-2 Testing Increased After a Federal Government’s At-Home Testing Distribution Program Compared with Before in a U.S. Urban Setting

Shruti H. Mehta, Jacky M. Jennings, Jason E. Farley, Saifuddin Ahmed, Suzanne M. Dolwick Grieb, Gregory Dale Kirk, Jamie Perin, Kelly Lowensen, Cheryl Himmelfarb, Penelope Schenkel, Jessica Wagner Duchen, Alexandra K. Mueller
article en

Abstract

Diagnostic testing is essential for controlling the transmission of infectious diseases. During the COVID-19 pandemic, testing became widely available in the United States. However, the association between a federal at-home COVID-19 rapid antigen test distribution program and sociodemographics and COVID-19 testing remains unknown. This secondary analysis aims to (1) assess the association between the federal at-home testing program and testing uptake and (2) examine associations, including interactions with the testing program, between sociodemographic characteristics, testing experience, and COVID-19 testing. We analyzed baseline data collected from February 2021 to November 2022 in a randomized comparative effectiveness parent trial conducted in a mid-Atlantic U.S. city ( N = 1859). Logistic regression models with robust standard errors were used. Overall, 79.9% (1486) of participants reported receiving a COVID-19 test. Exposure to the federal testing program (odds ratio [OR] = 2.25; 95% confidence interval [CI]: 1.61, 3.13), higher education (OR = 1.36; 95% CI: 1.02, 1.80), private health insurance (OR = 2.03; 95% CI: 1.41, 2.92), higher household income (OR = 1.49; 95% CI: 1.06, 2.09), and ease of testing access (OR = 1.40; 95% CI: 1.04, 1.87) were significantly associated with testing. After adjustment, private insurance (adjusted OR [aOR] = 1.61; 95% CI: 1.12, 2.31) and higher income (aOR = 1.50; 95% CI: 1.12, 2.02) remained associated with testing. The adjusted odds of COVID-19 testing were 2-fold higher (aOR = 2.21; 95% CI: 1.21, 4.04) for high-income (vs. low-income) households during the federal at-home COVID-19 rapid antigen testing program than before its implementation. Disparities in COVID-19 testing by socioeconomic status increased during the federal testing program compared with the period before its implementation. Ensuring equitable access to diagnostic testing remains critical for an effective public health response.

Population Health Management
Johns Hopkins University (US)
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon